SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus / COVID-19 Pandemic
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Moonray8/28/2020 8:50:55 PM
1 Recommendation

Recommended By
Glenn Petersen

   of 22882
 
Abbott Labs is doing trials of its rapid
coronavirus test on people without symptoms
Kevin Stankiewicz

Abbott Laboratories CEO Robert Ford told CNBC that the company
is conducting trials of its rapid coronavirus test to determine its
efficacy for people without symptoms.

Earlier this week, the Illinois-based firm announced it had received
emergency approval from the Food and Drug Administration to use
the test on people within seven days of symptom onset. The antigen
test, which sells for $5 and can produce results in 15 minutes, is a
notable development in the United States’ efforts to broaden its
screening capabilities for Covid-19.

“We are working on developing data for asymptomatic claims so we
are running our clinical trial and we’ll eventually have data to be able
to support that,” Ford said in an interview with CNBC’s Meg Tirrell on
“Power Lunch.”

o~~~ O
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News